Latest News

December 2021

Fujifilm Diosynth Biotechnologies, a world leading contract development and manufacturing organisation (CDMO) for biologics, viral vaccines and viral vectors, has confirmed a £400 million planned investment package at its UK facility in Billingham, Teesside:


GSK has announced that its antibody-based COVID-19 therapy with U.S. partner Vir Biotechnology is effective against all mutations of the new Omicron coronavirus variant, citing new data from early-stage studies:


Prof Dame Sarah Gilbert, whose University of Oxford team developed the Covid vaccine, says “Just as we invest in armed forces and intelligence and diplomacy to defend against wars, we must invest in people, research, manufacturing and institutions to defend against [future] pandemics.”


Fifty subjects have been enrolled in Helixmith Co., Ltd.’s double-blind placebo controlled COVID-19 clinical trial in India involving 100 subjects. The investigational product is called TADIOS, a proprietary botanical treatment:


The rising importance of the patient’s voice: how closed patient groups and other vehicles for empowering patients can contribute to improved understanding of their needs by pharma companies at all stages of the development pathway – from initial research and development to clinical trials:


Increasing use of AI in the life science sector has implications for the demand for laboratory real estate, with pharma companies and CROs establishing contractual wet labs that operate autonomously:


Despite the future predictions of shrinking demand for actual laboratory space as AI makes incursions into life sciences, the US is currently seeing explosive demand for laboratory space, and Biotech job openings are growing at their fastest pace on record:


AstraZeneca has announced for the first time it will seek to make modest profit from sales of the Covid jab in order to fund the development of a new Covid-19 treatment. It will also supply the vaccine at cost to developing nations:


A biochemist and a pioneer in the development of mRNA technology - used in both the Pfizer and Moderna vaccines - Hungarian-born Dr Katalin Karikó is the recipient of the 2021 Professor Hawking Fellowship:


Leslie Galloway, chairman of the Ethical Medicines Industry Group (EMIG) and an Expert Advisor within NICE, presents a brief review of the UK life sciences sector in 2021 with a quick look forward to next year:


Finally, we wish all our customers and website visitors a very happy and safe Christmas and New Year.


Oracle Partner NCC Group

Customer Area